These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 7607785

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D.
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A double-blind trial of mazindol using a very low calorie formula diet.
    Baird IM, Howard AN.
    Int J Obes; 1977 Apr; 1(3):271-8. PubMed ID: 363631
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients.
    Kopelman P, Bryson A, Hickling R, Rissanen A, Rossner S, Toubro S, Valensi P.
    Int J Obes (Lond); 2007 Mar; 31(3):494-9. PubMed ID: 16953261
    [Abstract] [Full Text] [Related]

  • 8. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H, Ziegler O, Keller U, Hamann A, Godin C, Wittert G, Zanella MT, Zúñiga-Guajardo S, Van Gaal L.
    Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
    [Abstract] [Full Text] [Related]

  • 9. Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine.
    Hainer V, Kunesova M, Bellisle F, Hill M, Braunerova R, Wagenknecht M.
    Int J Obes (Lond); 2005 Feb; 29(2):208-16. PubMed ID: 15583700
    [Abstract] [Full Text] [Related]

  • 10. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L, Fanghänel G, Yamamoto J, Martínez-Rivas L, Campos-Franco E, Berber A.
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [Abstract] [Full Text] [Related]

  • 11. [The effect of sibutramine for the maintenance of weight loss. A randomized controlled clinical trial].
    Toubro S, Hansen DL, Hilsted JC, Porsborg PA, Astrup AV, STORM Study Group.
    Ugeskr Laeger; 2001 May 21; 163(21):2935-40. PubMed ID: 11402974
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity.
    Miyashita Y, Koide N, Ohtsuka M, Ozaki H, Itoh Y, Oyama T, Uetake T, Ariga K, Shirai K.
    Diabetes Res Clin Pract; 2004 Sep 21; 65(3):235-41. PubMed ID: 15331203
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of diet, exercise and anorexigenic drugs on serum thyroid hormones.
    Sonka J, Límanová Z, Zbirková A, Kratochvíl O.
    Endokrinologie; 1980 Dec 21; 76(3):351-6. PubMed ID: 7472292
    [Abstract] [Full Text] [Related]

  • 17. Effects of sibutramine in overweight, poorly controlled Chinese female type 2 diabetic patients: a randomised, double-blind, placebo-controlled study.
    Wang TF, Pei D, Li JC, Tsai WC, Tsai CC, Yao CY, Chang ET, Hsieh MC, Su KY, Kuo SW.
    Int J Clin Pract; 2005 Jul 21; 59(7):746-50. PubMed ID: 15963197
    [Abstract] [Full Text] [Related]

  • 18. Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects.
    de Luis DA, Gonzalez Sagrado M, Conde R, Aller R, Izaola O.
    Ann Nutr Metab; 2007 Jul 21; 51(2):134-8. PubMed ID: 17536190
    [Abstract] [Full Text] [Related]

  • 19. [Effect of chitosan in complex management of obesity].
    Zahorska-Markiewicz B, Krotkiewski M, Olszanecka-Glinianowicz M, Zurakowski A.
    Pol Merkur Lekarski; 2002 Aug 21; 13(74):129-32. PubMed ID: 12420344
    [Abstract] [Full Text] [Related]

  • 20. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG, Weinstein SP, Rowe E, Ernst KR, Johnson F, Fujioka K, Sibutramine in Hypertensives Clinical Study Group.
    J Hum Hypertens; 2002 Jan 21; 16(1):5-11. PubMed ID: 11840224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.